🇺🇸 FDA

Company profile · Sponsor

Pierre

Pierre Fabre Australia Pty Ltd

ECE12DF · TGA pharma AU
Pipeline
3
Drugs
2
Patents
0

Quick answer

Pierre (ECE12DF) is a pharma company. headquartered in AU. listed on TGA. NovaPharmaNews links 3 pipeline programs, 2 drugs, and 0 patents to this profile..

Company facts

Ticker ECE12DF
Exchange TGA
Company type pharma
Headquarters AU

Pipeline (3)

Search pipeline →

  1. Gardasil 9 suspension for injection. Human Papillomavirus 9-valent Vaccine (Recombinant, adsorbed)

    Pierre

    giving a commercially available vaccine to women with HIV under treatment, women living with HIV traeted by antiretroviral

    approved small molecule active

    1 trial

  2. LIDOCAINE HYDROCHLORIDE, MORPHINE HYDROCHLORIDE

    Pierre

    sickle cell anaemia

    approved small molecule active

    1 trial

  3. The impact of extra-fine inhalation corticosteroid particles on small-airway disease in Chronic Obstructive Pulmonary Disease (COPD): a randomized, prospective cross-over trial.

    Pierre

    Chronic Obstructive Pulmonary Disease

    approved other active

    1 trial

Drugs (2)

Search drugs →

  1. binimetinib

    MEKTOVI

    ORAL approved

    L01EE03

  2. encorafenib

    BRAFTOVI

    ORAL approved

    L01EC03

Frequently asked questions

What is Pierre?

Pierre (ECE12DF) is a pharma company. headquartered in AU. listed on TGA. NovaPharmaNews links 3 pipeline programs, 2 drugs, and 0 patents to this profile..

What pipeline programs does Pierre sponsor?

We track 3 ClinicalTrials.gov-linked programs for Pierre, including Gardasil 9 suspension for injection. Human Papillomavirus 9-valent Vaccine (Recombinant, adsorbed) and 2 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Pierre company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.